WikiFX

Reply

As an experienced trader, I tend to scrutinize trading conditions and costs before engaging with any broker, especially when considering index CFDs like the US100. Reviewing Morrison's available information, I immediately noticed that, while Morrison is a long-standing, ASIC-regulated entity with a clear STP license, their primary focus is on cash equities, equity options, ETFs, bonds, and related Australian-listed products. Notably, the broker does not list indices—particularly global indices like the US100—among its tradable instruments. This absence is significant because it means traders seeking exposure to US index CFDs or similar contracts would not find them available for trading on Morrison’s platform. Additionally, my due diligence revealed an unclear fee structure overall. Even within Morrison's asset coverage, the transparent disclosure of spreads, commission rates, and any ancillary fees (such as overnight financing or administrative costs) is lacking on their public materials. For me, this is a critical detail; without explicit cost visibility, it’s difficult for any prudent trader to accurately assess their total trading costs or make comparisons to other brokers. Because Morrison does not support indices like the US100, and does not provide detailed cost breakdowns even for their available instruments, I would exercise caution. Personally, I always require clear instrument lists and a transparent fee schedule before considering a broker for trading—particularly for index products and active strategies sensitive to cost. For those with a similar focus, I’d suggest confirming asset availability and all related trading costs directly with the broker before proceeding.